Markets:

Overview

News

Currencies

International

Treasuries

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

72.83 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Halozyme Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Halozyme Therapeutics Earnings Preview ↗

May 08, 2023

Via Benzinga

Medicare Negotiation Hammers Biotech Stocks Regeneron, Halozyme ↗

March 16, 2023

It's still unclear whether CMS will include those drugs in its negotiation list.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

The Latest Analyst Ratings for Halozyme Therapeutics ↗

March 16, 2023

Via Benzinga

5 Analysts Have This to Say About Halozyme Therapeutics ↗

February 22, 2023

Via Benzinga

Halozyme Therapeutics's Earnings: A Preview ↗

February 20, 2023

Via Benzinga

Where Halozyme Therapeutics Stands With Analysts ↗

December 08, 2022

Via Benzinga

5 Analysts Have This to Say About Halozyme Therapeutics ↗

December 08, 2022

Via Benzinga

4 Analysts Have This to Say About Halozyme Therapeutics ↗

November 22, 2022

Via Benzinga

Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review ↗

January 13, 2023

Sharp Tesla price cuts and some notable earnings were in focus.

Via Investor's Business Daily

Nasdaq Rises Over 1%; CommVault Systems Shares Plummet ↗

January 11, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Wednesday.

Via Benzinga

CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday ↗

January 11, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Halozyme Therapeutics Shares Jump On Better Than Expected Annual Guidance ↗

August 10, 2022

Via Benzinga

Why Broadwind Shares Are Trading Higher By 85%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 11, 2023

Gainers Broadwind Inc (NASDAQ: BWEN) shares climbed 85.4% to $4.19 after the company announced the receipt of approximately $175 million in new tower orders from a leading global wind turbine...

Via Benzinga

US Stocks Open Higher; Nasdaq Rises 60 Points ↗

January 11, 2023

U.S. stocks traded higher this morning, with the Nasdaq gaining around than 600 points on Wednesday.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 28, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

December 01, 2022

During Thursday's session, 108 stocks hit new 52-week highs.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 ↗

November 28, 2022

Via Benzinga

Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review ↗

November 22, 2022

Via Benzinga

Amazon To $103? Plus Piper Sandler Predicts $300 For Illumina ↗

November 14, 2022

Rosenblatt boosted the price target on Amazon.com, Inc. (NASDAQ: AMZN) from $118 to $103. Rosenblatt analyst Barton Crockett maintained the stock with a Neutral rating. Amazon shares fell 4.3% to close...

Via Benzinga

Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review ↗

November 11, 2022

Bitcoin hit a two-year low while Meta and Tesla were in focus.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Friday ↗

November 25, 2022

On Friday, 68 companies reached new 52-week highs.

Via Benzinga

Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday ↗

November 09, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Argenx Seeks FDA Nod For Its Flagship Neuromuscular Treatment Formulated For Subcutaneous Injection ↗

September 21, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022 ↗

September 09, 2022

Upgrades

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 15, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Halozyme Therapeutics: Q2 Earnings Insights ↗

August 09, 2022

Halozyme Therapeutics (NASDAQ:HALO) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 02, 2022

Via Benzinga

Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study ↗

August 02, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Biotech Stocks With Key Catalysts Coming in July ↗

June 27, 2022

Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.

Via InvestorPlace

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Halozyme Therapeutics, Inc. - Common Stock (NQ:HALO)

All News about Halozyme Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today